FBI Is Investigating Hysterectomy Device Found to Spread Uterine Cancer

The morcellator surgical tool was found to spread uterine cancer, and the FBI is examining what the largest maker of it, Johnson & Johnson, knew about the hazards The FBI is investigating a surgical device that was found to spread cancer in women, including looking into what the largest manufacturer of it, Johnson & Johnson, knew about the tool’s hazards before pulling it off the market last year, according to people who have been interviewed by the agency. It is unclear what stage the inquiry is in.

Price’s Health Reform Hit From The Right

I recently discussed Rep. Tom Price, MD’s Empowering Patients First Act in quite positive terms. Not everyone is on board. My good friend Dean Clancy labels the bill Health Care Cronyism: Section 401, for example, authorizes new federal “best practice” guidelines written by medical societies, designed to give physicians extra protections from malpractice lawsuits. These guidelines aren’t merely educational, though. They’re established as powerful litigation tools in state courts. If a physician can show he followed them, his accuser must meet a higher burden of proof to establish negligence. That may be a good idea, but it’s unconstitutional. The power to regulate civil justice is reserved to the states under our federal system. There’s neither a legal nor a practical justification for federal

Health Affairs Web First: Are Marketplace Enrollees Sicker Than Those With Employer-Sponsored Insurance?

To date little is known about the health status of the 7.3 million Americans who signed up for health insurance through either federal- or state-run exchanges created by the Affordable Care Act (ACA). One effective way to gain information is to examine their use of prescription drugs. A new study, being released by Health Affairs as a Web First, compared prescription data from January to September of 2014 of more than one million Marketplace enrollees. The study reviewed the characteristics and medication use of early enrollees (October 1, 2013 through February 28, 2014) and those enrolling later (between March 1 and May 31, 2014), and compared those findings with a sample of some one million Americans enrolled in employer-sponsored health coverage. There were three key findings, which have implications for understanding the